
Evotec
Europe, Hamburg, Germany, Hamburg
Description
Evotec is a pharmaceutical and life science company that provides drug discovery and gene therapy solutions.
Investor Profile
Evotec has made 27 investments, with 1 in the past 12 months and 19% as lead.
Stage Focus
- Series A (37%)
- Series B (22%)
- Series C (11%)
- Seed (11%)
- Series Unknown (7%)
- Corporate Round (4%)
- Post Ipo Equity (4%)
- Pre Seed (4%)
Country Focus
- United States (33%)
- Germany (22%)
- United Kingdom (22%)
- Ireland (7%)
- France (7%)
- Spain (4%)
- Italy (4%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Therapeutics
- Life Science
- Artificial Intelligence (Ai)
- Medical
- Oncology
- Genetics
- Biopharma
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.